Consun Pharmaceutical continues share buyback program in October

Consun Pharmaceutical Group Limited reported a series of share repurchases between October 14 and October 27, 2025, as part of its ongoing buyback program. On October 27, 2025, the company repurchased an additional 100,000 ordinary shares on the Exchange at a price of HK$15.4 per share, totaling HK$1,540,000 for the day's transaction.

These repurchases contribute to a total of 1,911,000 shares bought back between October 14 and October 27, 2025, which are currently awaiting cancellation. The cumulative number of shares repurchased on the Exchange under the current mandate stands at 7,406,000. This represents 8.7% of the company's issued shares as of the resolution date granting the repurchase mandate (May 22, 2025), which authorized a total of 85,126,334 shares for repurchase.

As of October 27, 2025, the company's closing balance of issued ordinary shares remains at 847,973,407. The moratorium period for any new share issue or sale/transfer of treasury shares after these repurchases extends until November 26, 2025.